Gedivumab clinical trials
Also written MHAA4549A.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses gedivumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- MHAA4549A
- 4
Studies by the year they started
4 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses gedivumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy AdultsCompletedPhase 2Genentech, Inc.NCT02623322Written as MHAA4549A
- A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A InfectionCompletedPhase 2Genentech, Inc.NCT02293863Written as MHAA4549A
- A Study of High Dose MHAA4549A in Healthy VolunteersCompletedPhase 1Genentech, Inc.NCT02284607Written as MHAA4549A
- A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy VolunteersCompletedPhase 1Genentech, Inc.NCT01877785Written as MHAA4549A
Codes
What other systems call gedivumab · ClinicalTrials.gg INT001108
- MeSH (NLM) C000631565gedivumabOne source NLM
- UNII (FDA) 6IRE1TI49IGEDIVUMABConfirmed FDA, NLM
- NCI Thesaurus C166943GedivumabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000631565 | gedivumab | One source NLM |
| UNII (FDA) | 6IRE1TI49I | GEDIVUMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C166943 | Gedivumab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.